Quarterly report pursuant to Section 13 or 15(d)

Equity Transactions (Details Narrative)

v3.19.3
Equity Transactions (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Aug. 14, 2019
Apr. 30, 2019
Apr. 09, 2019
Apr. 04, 2019
Apr. 30, 2019
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Number of shares issued               1,196,000    
Warrant to purchase of common stock           108,196   108,196    
Value of shares issued for acquisition               $ 7,820,000    
Number of common stock shares issued for service, value           $ 202,000 $ (1,080,000) $ 930,000 $ 1,547,000  
Number of stock options granted               735,667    
Debt conversion amount             788,000   3,066,000  
Stock options intrinsic value               $ 2,660,000
Exercise price of common stock granted               $ 3.97    
Fair value of warrants           $ 215,000   $ 215,000    
Proceeds from warrant exercise               $ 45,000 $ 22,000  
Series A Preferred Stock [Member]                    
Number of shares issued 5,030                  
Note Holder [Member]                    
Number of stock options granted               25,272    
Number of stock options granted, value               $ 182,000    
Notes Payable [Member]                    
Number of common stock shares issued upon conversion               780,619    
Debt conversion amount               $ 1,129,000    
Accounts Payable [Member]                    
Debt conversion amount   $ 10,000                
Conversion of accounts payable into common stock shares   4,142                
Conversion of accounts payable into common stock   $ 10,000                
Convertible Notes Payable [Member]                    
Warrant to purchase of common stock           108,196   108,196    
Warrant exercise price           $ 3.44   $ 3.44    
Warrant expiration date           Jul. 31, 2024   Jul. 31, 2024    
Fair value of warrants           $ 217,000   $ 217,000    
Vendor [Member]                    
Number of common stock shares issued for service               354,288    
Number of common stock shares issued for service, value               $ 930,000    
Employees and Consultant [Member]                    
Number of stock options granted               735,667    
Exercise price of common stock granted               $ 3.97    
Options expiration period, description               one or five years    
Options vesting percentage               100.00%    
Stock option vesting period               The options have an average exercise price of $3.97 per share, expire in one or five years, and vests (i) 100% on the grant date, (ii) 50% on the grant date and the remaining 50% on the 12-month anniversary of the grant date, (iii) in three equal installments during the three years from the grant date, (iv) in 4 equal installments during the four years from the grant date, or (v) in 12 equal installments based on achieving performance targets during the three years from the grant date.    
Fair value of stock options grants               $ 2,155,000    
Expense recognized relating to stock options               1,505,000    
Unrecognized stock based compensation expense           $ 4,300,000   $ 4,300,000    
Common Stock [Member]                    
Number of shares issued                 1,163,938  
Number of shares issued for acquisition         3,327,791     3,327,791    
Value of shares issued for acquisition         $ 7,820,000        
Number of common stock shares issued for service           156,478   354,288 319,346  
Number of common stock shares issued for service, value            
Number of common stock shares issued upon conversion             750,988   1,243,189  
Debt conversion amount                
Series A Preferred Stock and Warrants [Member]                    
Proceeds from issuance of preferred shares and warrants $ 4,688,000                  
Direct costs of issuance 342,000                  
Warrant [Member]                    
Warrant to purchase of common stock           163,739   163,739    
Warrant exercise price           $ 3.76   $ 3.76    
Warrant expiration date           Apr. 30, 2024   Apr. 30, 2024    
Direct costs of issuance 1,485,000                  
Derivative liability 6,173,000                  
Reduction to additional paid in capital $ 4,688,000                  
Stock options intrinsic value           $ 0   $ 0    
Fair value of warrants           $ 439,000   $ 439,000    
Number of warrants exercised               186,969    
Warrant [Member]                    
Warrant exercise price           $ 1.15   $ 1.15    
Conversion of accounts payable into common stock shares               173,714    
Proceeds from warrant exercise               $ 45,000    
Public Offering [Member]                    
Proceeds from public offering     $ 18,524,000              
Other offering expense     $ 2,138,000              
Legal and professional expenses                   $ 162,000
Public Offering [Member] | Underwriter Warrants [Member]                    
Warrant to purchase of common stock     319,488              
Warrant exercise price     $ 3.913              
Public Offering [Member] | Common Stock [Member]                    
Warrant to purchase of common stock           6,869,084   6,869,084    
Warrant exercise price           $ 3.46   $ 3.46    
Warrant expiration date           Apr. 30, 2024   Apr. 30, 2024    
Preferred Stock Offering [Member]                    
Warrant to purchase of common stock           3,245,162   3,245,162    
Warrant exercise price           $ 1.88   $ 1.88    
Warrant expiration date           Aug. 31, 2024   Aug. 31, 2024    
Underwriting Agreement [Member]                    
Number of units issued under offering     6,389,776              
Number of shares issued     6,389,776              
Warrant to purchase of common stock     6,389,776              
Underwriting Agreement [Member] | Over-allotment Option [Member]                    
Number of units issued under offering     159,820              
Number of shares issued     159,820              
Warrant to purchase of common stock     159,820              
Underwriting Agreement [Member] | Alliance Global Partners [Member]                    
Number of units issued under offering       6,389,776            
Number of shares issued       6,389,776            
Warrant to purchase of common stock       6,389,776            
Shares issued price per share       $ 3.13            
Underwriting Agreement [Member] | Alliance Global Partners [Member] | Option Shares [Member]                    
Number of units issued under offering       958,466            
Number of shares issued       958,466            
Warrant to purchase of common stock       958,466            
Warrant exercise price       $ 3.443            
Warrant term       5 years            
Warrant expiration date       Apr. 09, 2024            
Securities Purchase Agreement [Member]                    
Number of shares issued 5,030                  
Warrant to purchase of common stock 3,870,000                  
Warrant exercise price $ 1.88                  
Conversion of stock, number of shares issued 3,870,000                  
Securities Purchase Agreement [Member] | Maximum [Member]                    
Warrant to purchase of common stock 3,870,000                  
Number of share warrants granted to issue 3,245,162                  
Securities Purchase Agreement [Member] | Series A Preferred Stock [Member]                    
Number of shares agreed to be issued 6,000                  
Preferred stock conversion, description Each share of Series A Preferred Stock is convertible, at any time and from time to time from and after the issuance date, at the holder’s option in to that number of shares of Common Stock equal to the stated value per share (or $1,000) divided by the conversion price (initially, $1.55); thus, initially, each share of Series A Preferred Stock is convertible into approximately 645 shares of Common Stock. In certain circumstances, the Series A Preferred Stock is mandatorily convertible into shares of Common Stock after the Company obtains stockholder approval to issue a number of shares of Common Stock in excess of 19.99% and the closing price of the Common Stock is 100% greater than the then-base conversion price on each trading day for any 20 trading days during a consecutive 30-trading-day period. The holders of Series A Preferred Stock cannot convert the Series A Preferred Stock if, after giving effect to the conversion, the number of shares of our Common Stock beneficially held by the holder (together with such holder’s affiliates) would be in excess of 4.99% (or, upon election by a holder prior to the issuance of any shares, 9.99% of the number of shares of Common Stock issued and outstanding immediately after giving effect to the issuance of any shares of Common Stock issuance upon conversion of the Series A Preferred Stock held by the holder). The conversion price of the Series A Preferred Stock is subject to certain customary adjustments, including upon certain subsequent equity sales and rights offerings.                  
Securities Purchase Agreement [Member] | Series A Preferred Stock and Warrants [Member]                    
At-the-market agreement terms, description We are also prohibited, until the date that the Preferred Purchasers no longer collectively hold at least 20% of the then-outstanding shares of Series A Preferred Stock issued pursuant to the SPA, from entering into an agreement to effect any issuance by us of Common Stock or Common Stock equivalents involving certain variable rate transactions. We also cannot enter into agreements related to “at-the-market” transactions for a period of 12 months. At the later of (i) the date that the Warrants are fully exercised, and (ii) 12 months from the date of the SPA, we cannot draw down on any existing or future agreement with respect to “at-the-market” transactions if the sale of the shares in such transactions has a per share purchase price that is less than $3.76 (two times the exercise price of the Warrants).                  
Preferred stock conversion, description Each share of Series A Preferred Stock is convertible, at any time and from time to time from and after the issuance date, at the holder’s option in to that number of shares of Common Stock equal to the stated value per share (or $1,000) divided by the conversion price (initially, $1.55); thus, initially, each share of Series A Preferred Stock is convertible into approximately 645 shares of Common Stock. In certain circumstances, the Series A Preferred Stock is mandatorily convertible into shares of Common Stock after the Company obtains stockholder approval to issue a number of shares of Common Stock in excess of 19.99% and the closing price of the Common Stock is 100% greater than the then-base conversion price on each trading day for any 20 trading days during a consecutive 30-trading-day period. The holders of Series A Preferred Stock cannot convert the Series A Preferred Stock if, after giving effect to the conversion, the number of shares of our Common Stock beneficially held by the holder (together with such holder’s affiliates) would be in excess of 4.99% (or, upon election by a holder prior to the issuance of any shares, 9.99% of the number of shares of Common Stock issued and outstanding immediately after giving effect to the issuance of any shares of Common Stock issuance upon conversion of the Series A Preferred Stock held by the holder). The conversion price of the Series A Preferred Stock is subject to certain customary adjustments, including upon certain subsequent equity sales and rights offerings.                  
Conversion price per share $ 1.55                  
Shareholders' approval percentage for mandatory conversion 19.99%                  
Number of common stock to be issued causing ineligibility to issue common stock 4,459,725